Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of Massachusetts, Worcester
With
Massachusetts Institute of Technology
Breast Cancer Research Foundation
Age
40–any
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Women who were identified as high risk on the retrospective study (dating from 2017-2025) using MIRAI will be recruited and consented for the prospective study
Women over 40 years of age identified as high risk according to traditional guidelines will also be potentially eligible for this study
Following consent and enrollment in the study, a participant will subsequently receive the following:
1. These patients will be invited to receive a supplemental MRI examination currently considered the most sensitive test for breast cancer detection.
2. Any positive diagnosis on MRI will be followed by biopsy to confirm 'truth" of diagnosis.
To be selected, a given record must include the following:
1. A report of a routine screening mammogram or diagnostic mammogram, and availability of the DICOM images from that report with the PACS system.
2. Reports of all follow up screening and diagnostic studies documented on PACS.
3. Some may have interventional procedures (as long as all of these are done at one of Umass sites) and documentation of these biopsy results in the hospitals EHR.
You may not be if
Under age 40. Women under 40 years are not routinely xrayed with a mammogram.
Xray breast cancer screening imaging study that has artifacts, corruption, or other image quality degradation.
Pregnant patients because they do not routinely receive screening mammogram
Adult male patients with breast cancer
Clareo Health | MIRAI-MRI: Comparing Screening MRI for Patients at High Risk for Breast Cancer Identified by Mirai and Tyrer-Cuzick
